Method and system for treating cardiac arrest using hypothermia

ABSTRACT

A method for treating cardiac arrest includes defibrillating the patient and/or ventilating the patient and/or administering a cardiac arrest drug such as epinephrine to resuscitate the patient, and then cooling the patient using one or more cooling catheter positioned in the central venous system of the patient.

RELATED APPLICATIONS

[0001] Priority is claimed from co-pending U.S. patent application Ser.No. 09/266,452, filed Mar. 11, 1999.

FIELD OF THE INVENTION

[0002] The present invention relates to methods and systems for treatingcardiac arrest.

BACKGROUND

[0003] It has been discovered that the medical outcome for a patientsuffering from severe brain trauma or from ischemia caused by stroke orheart attack is improved if the patient is cooled below normal bodytemperature (38° C.). As understood by the present invention, themedical outcome for many such patients might be significantly improvedif the patients were to be moderately cooled to 32° C.-34° C. relativelyquickly after an ischemic insult for a short period, e.g., 12-72 hours.It is believed that such cooling improves cardiac arrest patientoutcomes by improving the mortality rate, in that many organs canbenefit from the cooling, and by improving the neurological outcome forthose patients that survive.

[0004] Systems and methods have been disclosed that propose coolingblood flowing to the brain through the carotid artery. An example ofsuch systems and methods is disclosed in co-pending U.S. pat. app. Ser.No. 09/063,984, filed Apr. 21, 1998, owned by the present assignee andincorporated herein by reference. In the referenced application, variouscatheters are disclosed which can be advanced into a patient's carotidartery and through which coolant can be pumped in a closed circuit, toremove heat from the blood in the carotid artery and thereby cool thebrain. The referenced devices have the advantage over other methods ofcooling (e.g., wrapping patients in cold blankets) of beingcontrollable, relatively easy to use, and of being capable of rapidlycooling and maintaining blood temperature at a desired set point.

[0005] As recognized in co-pending U.S. pat. app. Ser. No. 09/133,813,filed Aug. 13, 1998, owned by the present assignee and incorporatedherein by reference, the above-mentioned advantages in treating ischemiaby cooling can also be realized by cooling the patient's entire body,i.e., by inducing systemic hypothermia The advantage of systemichypothermia is that, as recognized by the present assignee, to inducesystemic hypothermia a cooling catheter or other cooling device need notbe advanced into the blood supply of the brain, but rather can be easilyand quickly placed into the relatively large vena cava of the centralvenous system. Moreover, since many patients already are intubated withcentral venous catheters for other clinically approved purposes anyway,providing a central venous catheter that can also cool the bloodrequires no additional surgical procedures for those patients. A coolingcentral venous catheter is disclosed in the present assignee'sco-pending U.S. patent application Ser. No. 09/253,109, filed Feb. 19,1999 and Ser. No. 09/305,613, filed May 5, 1999, both of which areincorporated herein by reference.

[0006] The present invention understands that the above-mentionedbenefits of hypothermia might be particularly suited for treatingcardiac arrest. This is because outcomes for cardiac arrest patientscurrently are very poor, even when the patients can be resuscitated,since brain damage occurs as a result of the global ischemia caused bylack of blood flow before resuscitation. The severity of such braindamage, as understood herein, can potentially be alleviated byhypothermia.

SUMMARY OF THE INVENTION

[0007] A kit for lowering a patient's temperature includes a firstcatheter that has at least one fluid circulation passageway connectableto a source of coolant. In accordance with the present invention, thefirst catheter is configured for placement in a patient's vena cava viaa groin entry point. Also, a second catheter has at least one fluidcirculation passageway connectable to a source of coolant. As set forthbelow, the second catheter is configured for placement in a patient'scirculatory system via a neck entry point.

[0008] In a preferred embodiment, the kit can include the source ofcoolant. Preferably, the source of coolant includes at least one thermalelectric cooler (TEC) for heating or cooling coolant such that coolantis returned to the catheter to heat or cool the catheter. The kit can beincorporated in system that includes a ventilation system, and/or adefibrillator system, and/or a component containing a drug selected fromthe group consisting of: epinephrine, buffers, antiarrhythmics, andatropine.

[0009] In another aspect, a method for treating cardiac arrest in apatent includes defibrillating the patient, and lowering the.patient'stemperature using at least one catheter placed in the venous system ofthe patient

[0010] In still another aspect, a method for treating cardiac arrestusing hypothermia includes resuscitating the patient and inducinghypothermia in the patient.

[0011] In yet another aspect, a system for treating cardiac arrest in apatient includes at least one cooling catheter that is advanceable intothe central venous system of the patient. The system further includesone or more of: a defibrillator, a ventilator, and a cardiac arrest drugdelivery device engageable with the patient.

[0012] The details of the present invention, both as to its structureand operation, can best be understood in reference to the accompanyingdrawings, in which like reference numerals refer to like parts, and inwhich:

BRIEF DESCRIPTION OF THE DRAWINGS

[0013]FIG. 1 is a schematic view of the cooling system using the firstcooling catheter;

[0014]FIG. 2 is a schematic view of the cooling system using the secondcooling catheter;

[0015]FIG. 3 is a flow chart of the present invention for treatingcardiac arrest in a patient; and

[0016]FIG. 4 is a flow chart of the steps for cardiopulmonaryresuscitation (CPR).

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

[0017] Referring initially to FIG. 1, a therapeutic system, generallydesignated 10, is shown for treating cardiac arrest in a patient 12. Asshown, the system 10 includes a cooling system 14 that can be awater-bath system such as the system disclosed in the present assignee'sco-pending U.S. patent application Ser. No. 09/220,897 filed Dec. 28,1998 and incorporated herein by reference, or a cooling system includingat least one thermal electric cooler (TEC) 16, as disclosed in thepresent assignee's co-pending U.S. patent application Ser. No.09/260,950, filed Mar. 2, 1999 and incorporated herein by reference. Inany case, the cooling system 14 can be considered a source of coolant,preferably sterile saline, for the catheters of the present invention.

[0018] As set forth in these applications, the cooling system 14 caninclude a heat exchanger, a pump, and, if desired, a controller.Preferably, the pump is a peristaltic pump, but other types of positivedisplacement pumps, such as but not limited to piston pumps and gearpumps, or even centrifugal pumps, can be used. A peristaltic pump ispreferred in the present implementation because it can pump coolantwithout directly contacting the coolant, but instead simply by squeezinga tube through which the coolant flows. In this way, the pump isreusable, and only the present catheters and portions of the system 10coming in direct contact with the coolant need be made disposable torender an advantageously disposable and sterile coolant delivery system.The controller controls the rate at which coolant is pumped by the pumpand, if desired, the rate at which heat is added or subtracted from thecoolant. The controller can be implemented by a software-executingprocessor or by discrete logic circuits or other electronic circuitrydevice to establish a desired patient temperature by appropriatelycontrolling the pump and/or heat exchanger in response to a temperaturesignal derived from a sensor in the patient 12.

[0019] As shown in FIG. 1, a first cooling catheter 18 can communicatewith the cooling system 14 via coolant supply and return lines 20, 22.The coolant lines 20, 22 can be IV lines or tubes or other suitablefluid conduits, such as metal (steel) tubes. When the coolant lines 20,22 are plastic tubes, they can be connected to the catheter 18 and thecooling system 14 by suitable connecting structure, such as Luerfittings, interference fits, solvent bonding, heat staking, ultrasonicwelding, and the like.

[0020] The first cooling catheter 18 includes a heat exchange region 24.The heat exchange region 24 can be established by one or more hollowfibers, as disclosed in the above-referenced U.S. patent applicationSer. No. 09/133,813. Alternatively, the heat exchange region 24 caninclude one or more cooling membranes such as balloons as disclosed inthe above-referenced U.S. patent application Ser. Nos. 09/253,109 and09/305,613. For example, the heat exchange region 24 of the firstcatheter 18 can be established by four axially staggered balloons, eachten millimeters in diameter when inflated with coolant.

[0021] In any case, as set forth in the referenced applications, coolantis circulated in a closed fluid communication loop between the heat.exchange region 24 and cooling system 14 to remove heat from the patient12. As set forth in greater detail below, the first catheter 18 isadvanced (preferably through an introducer sheath) into the vena cava ofthe patient 12 through a groin entry point 26 to establish hypothermiain the patient 12. Preferably, the catheter 18 is advanced eitherthrough the saphenous vein or femoral vein in accordance with the methoddescribed below.

[0022] In addition to or in lieu of the first catheter 18, a secondcooling catheter 28 (FIG. 2) which is configured for use as a centralvenous catheter can be advanced into the central venous system of thepatient through a neck entry point 29. The second catheter 28 can beembodied by the catheter disclosed in the above-referenced patentapplications Ser. No. 09/253,109 and 09/305,613. Accordingly, the secondcatheter 28 can communicate with the cooling system 14 via coolantsupply and return lines 30, 32. Also, the second catheter 28 cancommunicate with one or more central venous components 34, such as IVinfusion devices, drug delivery syringes for infusing epinephrine, bloodwithdrawal devices, and so on.

[0023] As disclosed in the referenced applications, the second catheter28 includes a heat exchange region 36 that can be established by one ormore membranes such as balloons, although it could be established byhollow fibers in the manner of the catheter 18, but on a smaller scale.The catheter 28 can be advanced into the superior vena cava through thejugular vein or subclavian vein to cool the patient 12 by means ofcoolant circulating in a closed loop between the cooling system 14 andthe balloon 36. As mentioned above, the second catheter 28 can also beused to undertake conventional central venous catheter functions.

[0024] Referring back to FIG. 1, in addition to the cooling componentsdiscussed above, the system 10 can include a heart defibrillator system38 that can be engaged with the patient 12 by means of one or moredefibrillator connecting lines 40 with associated engagingpaddles/electrodes 41. Moreover, the system 10 can include a ventilationsystem 42 that ventilates the patient 12 by means of an endotrachealtube 44 or other equivalent device such as a ventilating mask.

[0025] The process of the present invention can be appreciated inreference to FIG. 3. Commencing at block 46, basic life supportalgorithms are undertaken on a patient suffering from cardiac arrest.The basic life support activities can include or more of thecardiopulmnary resuscitation (CPR) acts discussed below in reference toFIG. 4.

[0026] At block 48, in an attempt to quickly start the patient's heartbeating again, particularly in the absence of a defibrillator, aprecordial thump can be administered to the patient's chest. Inaddition, or if and when the defibrillator system 38 becomes available,at block 50 the defibrillator is engaged with the patient and thepatient is defibrillated to start the patient's heart beating.

[0027] After initial defibrillation, the patient's heart rhythm isassessed at block 52. At decision diamond 54 it is determined inaccordance with cardiac arrest resuscitation standards whether thepatient exhibits ventricular fibrillation (VF) or ventriculartachycardia (VT). VF is defined as a pulseless, chaotic, disorganizedrhythm characterized by an undulating irregular pattern that varies insize and shape with a ventricular waveform greater than 150 beats perminute. If no VF/VT is detected, indicating that the patient's heart isbeating normally, some or all of the CPR acts shown in FIG. 4 areadministered as necessary at block 56 for, e.g., up to three minutes.

[0028] If, on the other hand, it is determined at decision diamond 56that the patient exhibits VF/VT, the patient is defibrillated up to,e.g., three times at block 58. In one preferred embodiment,defibrillation energy levels are 200 J (2 J/kg) for the first shock,200J-300J (24 J/kg) for the second shock, and 360J (4J/kg) for the thirdand subsequent shocks (weight-based dosages are pediatricrecommendations). CPR is then administered at block 60 for up to, e.g.,one minute.

[0029] In accordance with the present invention, after defibrillationand CPR, moderate hypothermia is induced in the patient at block 62 toalleviate the results of global ischemia arising from cardiac arrest. Itis to be understood that the step shown at block 62 can be undertaken atother convenient times including before defibrillation and CPR orconcurrently therewith. In any case, the patient's temperature islowered below normal body temperature, and as low as 32° C., byadvancing one or both of the catheters 18, 28 into the patient 12 andthen circulating coolant through the catheter 18, 28.

[0030] In one embodiment of the present method, the first catheter 18is. initially advanced into the vena cava through the groin to cool thepatient while resuscitation personnel require access to the neck forintubation and for establishing rapid IV access. When CPR is complete,the second catheter 28 can be advanced into the vena cava through therelatively less septic neck, and if desired the first catheter 18 can beremoved from the relatively more septic groin area. It is to beunderstood that while this is one preferred sequence of the order ofsteps for inducing hypothermia in a cardiac arrest patient, othersequences can be used. For example, the first catheter 18 can be usedexclusively to the second catheter 28, the second catheter 28 can beused exclusively to the first catheter 18, or both catheters 18, 28 canbe used together simultaneously.

[0031]FIG. 4 shows that CPR can include but need not be limited tochecking defibrillator electrode/paddle engagement on the patient atblock 64. Also, CPR can include establishing endotracheal access withthe ET tube 44 at block 66 and then ventilating the patient using theventilation system 42. If tracheal intubation is not possible, alaryngeal mask airway or Combitube can be used as alternatives.

[0032] Moreover, at block 68 intravenous (IV) access can be establishedusing one of the catheters 18, 28 or another catheter such as aSwan-Ganz catheter, and then cardiac arrest drugs such as epinephrinecan be administered. If IV access is not attainable, epinephrine can beadministered via the ET tube 44 using at least twice the intravasculardosage of at least 1 mg (0.01 mg/kg) every 3 minutes.

[0033] At block 70 other drugs can be considered for administrationincluding buffers, antiarrhythmics, and atropine, and the installationof a pacemaker can also be undertaken. Any causes that can be corrected(such as, e.g., blocked airways) are corrected at block 72.

[0034] While the particular METHOD AND APPARATUS FOR ESTABLISHING ANDMAINTAINING THERAPEUTIC HYPOTHERMIA as herein shown and described indetail is fully capable of attaining the above-described objects of theinvention, it is to be understood that it is the presently preferredembodiment of the present invention and is thus representative of thesubject matter which is broadly contemplated by the present invention,that the scope of the present invention fully encompasses otherembodiments which may become obvious to those skilled in the art, andthat the scope of the present invention is accordingly to be limited bynothing other than the appended claims, in which reference to an elementin the singular is not intended to mean “one and only one” unlessexplicitly so stated, but rather “one or more”. All structural andfunctional equivalents to the elements of the above-described preferredembodiment that are known or later come to be known to those of ordinaryskill in the art are expressly incorporated herein by reference and areintended to be encompassed by the present claims. Moreover, it is notnecessary for a device or method to address each and every problemsought to be solved by the present invention, for it to be encompassedby the present claims. Furthermore, no element, component, or methodstep in the present disclosure is intended to be dedicated to the publicregardless of whether the element, component, or method step isexplicitly recited in the claims. No claim element herein is to beconstrued under the provisions of 35 U.S.C. ?112, sixth paragraph,unless the element is expressly recited using the phrase “means for”.

What is claimed is:
 1. A kit, comprising: a first catheter having atleast one fluid circulation passageway connectable to a source ofcoolant, the first catheter being configured for placement in apatient's vena cava via a groin entry point; and a second catheterhaving at least one fluid circulation passageway connectable to a sourceof coolant, the second catheter being configured for placement in apatient's circulatory system via a neck entry point.
 2. The kit of claim1, further comprising the source of coolant.
 3. The kit of claim 2,wherein the source of coolant includes at least one thermal electriccooler (TEC) for heating or cooling coolant such that coolant isreturned to catheter to heat or cool the catheter.
 4. The kit of claim1, further comprising at least one ventilation system.
 5. The kit ofclaim 1, further comprising at least one defibrillator system.
 6. Thekit of claim 1, further comprising at least one component containing adrug selected from the group consisting of: epinephrine, buffers,antiarrhythmics, and atropine.
 7. A method for treating cardiac arrestin a patient, comprising the acts of: defibrillating the patient; andlowering the patient's temperature using at least one catheter placed inthe venous system of the patient.
 8. The method of claim 7, furthercomprising the act of administering a precordial thump to the patient.9. The method of claim 7, further comprising the act of ventilating thepatient.
 10. The method of claim 7, further comprising the act ofadministering epinephrine to the patient.
 11. The method of claim 7,further comprising the act of administering one or more of: buffers,antiarrhythmics, and atropine, to the patient.
 12. A method for treatingcardiac arrest using hypothermia, comprising the acts of: resuscitatingthe patient; and inducing hypothermia in the patient.
 13. The method ofclaim 12, wherein the resuscitating act includes at least one ofdefibrillating the patient administering a precordial thump to thepatient, ventilating the patient, and administering one or more of:epinephrine, buffers, antiarrhythmics, and atropine, to the patient. 14.The method of claim 13, wherein hypothermia is induced by circulatingcoolant through a catheter positioned in the patient's central venoussystem.
 15. A system for treating cardiac arrest in a patient,comprising: at least one cooling catheter advanceable into the centralvenous system of the patient; and at least one of: a defibrillator, aventilator, and a cardiac arrest drug delivery device engageable withthe patient.
 16. The system of claim 15, comprising at least two coolingcatheters.
 17. The system of claim 15, comprising a cooling system forheat exchange with coolant flowing through the cooling catheter.
 18. Thesystem of claim 15, comprising a defibrillator and cardiac arrest drugdelivery device engageable with the patient to deliver epinephrine tothe patient.
 19. The system of claim 18, comprising a ventilator.